Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy.

Saved in:
Bibliographic Details
Title: Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy.
Authors: Yin N; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China., Zhang Z; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China., Ge Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China., Zhao Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China., Gu Z; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.; Zhengzhou University of Industrial Technology, Zhengzhou 450001, China., Yang Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China., Mao L; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China., Wei Z; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China., Liu J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou 450001, China., Shi J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of Key Drug Preparation Technology Ministry of Education, Zhengzhou 450001, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou 450001, China., Wang Z; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China.; Key Laboratory of 'Runliang' Antiviral Medicines Research and Development, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China.; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake 15#, Zhengzhou 450046, China.
Source: Science advances [Sci Adv] 2023 Jun 16; Vol. 9 (24), pp. eadf4098. Date of Electronic Publication: 2023 Jun 14.
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2375-2548
DOI:10.1126/sciadv.adf4098